Summit Therapeutics
CompanyMiami, United States· Biotech
US oncology drug developer.
Minutes holds 1 development and 1 deal naming Summit Therapeutics, recorded from September 2026.
Intelligence
Investors in rounds covered by Minutes
Deals in Minutes
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Summit TherapeuticsPharma | FundingEquity investment with alliance | $2B | Investors AstraZeneca | 29 Sep | Announced |
- FundingEquity investment with alliance, with AstraZenecaPharma · 29 Sep · Announced